Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective radiosensitization by nitric oxide in tumor cell lines.

Lucía Policastro1, Hebe Duran, Yann Henry

  • 1Departamento de Radiobiología, Comisión Nacional de Energía Atómica, Av. Gral. Paz 1499, B1650KNA San Martín, Provincia de Buenos Aires, Argentina.

Cancer Letters
|August 11, 2006
PubMed
Summary

Nitric oxide (NO) enhances radiation therapy effectiveness. Tumor cells with higher malignancy showed greater radiosensitization when pre-treated with the NO donor diethylenetriamine-NO (DETA-NO), suggesting potential for targeted cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential biological effects of scattered versus scanned clinical proton beams on Ewing sarcoma models.

Radiation oncology (London, England)·2026
Same author

Unraveling the role of boron microdistribution in BNCT dosimetry of glioblastoma multiforme: combined theoretical and experimental insights.

Physics in medicine and biology·2026
Same author

Sparing effects of FLASH irradiation in patient-derived lung tissue.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy.

Life sciences·2025
Same author

Radiosensitization Following Valproic Acid and Gamma Rays in Anaplastic Thyroid Cancer Cells Increases the Expression of hsa-miR-26a-5p.

Archives of medical research·2025
Same author

Novel doxycycline gold nanoparticles <i>via</i> green synthesis using PEO-PPO block copolymers for enhanced radiosensitization of melanoma.

Biomaterials science·2025

Area of Science:

  • Oncology
  • Radiation Biology
  • Medical Chemistry

Background:

  • Nitric oxide (NO) plays a complex role in biological systems.
  • Understanding NO's interaction with radiation is crucial for cancer therapy.
  • Diethylenetriamine-NO (DETA-NO) is a nitric oxide donor.

Purpose of the Study:

  • To evaluate the radiosensitizing effect of nitric oxide (NO) on tumor cells.
  • To investigate the relationship between tumor cell malignancy and radiosensitization by NO.
  • To assess the potential of NO donors in radiotherapy.

Main Methods:

  • Mouse and human tumor cell lines with varying malignancy were used.
  • Cells were pre-treated with the NO donor diethylenetriamine-NO (DETA-NO).
  • Cells were subsequently irradiated with gamma rays, and survival curves were analyzed using the linear-quadratic model.

Related Experiment Videos

Main Results:

  • A direct correlation was observed between the degree of malignancy and radiosensitization.
  • More malignant cell lines exhibited a higher degree of radiosensitization when treated with DETA-NO.
  • The radiosensitizing effect was dependent on the cell line's malignancy.

Conclusions:

  • The study demonstrates a differential radiosensitizing effect of DETA-NO based on tumor cell malignancy.
  • NO donors like DETA-NO show promise for enhancing radiation therapy efficacy.
  • Targeted use of NO could improve radiation's effect on tumors versus normal tissues.